Adherium (ASX:ADRDA) Inventories, Finished Goods : A$0.77 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Adherium Inventories, Finished Goods?

Adherium's quarterly finished goods declined from Jun. 2023 (A$0.47 Mil) to Dec. 2023 (A$0.00 Mil) but then increased from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.77 Mil).

Adherium's annual finished goods increased from Jun. 2022 (A$0.11 Mil) to Jun. 2023 (A$0.47 Mil) and increased from Jun. 2023 (A$0.47 Mil) to Jun. 2024 (A$0.77 Mil).

Adherium Inventories, Finished Goods Historical Data

The historical data trend for Adherium's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium Inventories, Finished Goods Chart

Adherium Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Inventories, Finished Goods

Get a 7-Day Free Trial

0.10

0.09

0.11

0.47

0.77

Adherium Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Inventories, Finished Goods	Get a 7-Day Free Trial											0.11	-	0.47	-	0.77

Adherium Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Adherium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.adherium.com

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium Headlines

No Headlines